Alto Neuroscience ANRO
NYSE ANRO
$21.90 -0.30 (-1.35%)
As of: Oct 23, 2026 · 1:36 PM EDT

Alto Neuroscience (ANRO) Net Shares Issued and Repurchased (2023 - 2026)

Updated

Analysis

Alto Neuroscience (ANRO) Net Shares Issued and Repurchased (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued (Qtr)
1 Eli Lilly 1,134.76 Bn 1,103.34 Bn 19.71 Bn -1.60 Bn
2 Johnson & Johnson 634.69 Bn 554.55 Bn 17.30 Bn -966.00 Mn
3 AbbVie 506.51 Bn 479.62 Bn 12.70 Bn -9.00 Mn
4 Merck 357.95 Bn 312.33 Bn 12.21 Bn -714.00 Mn
5 Novartis Ag 293.14 Bn 257.13 Bn 11.24 Bn -1.20 Bn
6 Astrazeneca 265.38 Bn 239.06 Bn 12.86 Bn 6.00 Mn
7 Amgen 238.37 Bn 193.77 Bn 7.24 Bn -
8 Gilead Sciences 195.16 Bn 169.36 Bn 6.22 Bn -346.00 Mn
9 Pfizer 170.88 Bn 117.53 Bn 10.94 Bn -
10 Alto Neuroscience 937.82 Mn 116.02 Mn - 75,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 75,000.00
Mar 31, 2026 6,000.00
Dec 31, 2025 352,000.00
Sep 30, 2025 153,000.00
Mar 31, 2025 198,000.00
Dec 31, 2024 49,000.00
Sep 30, 2024 67,000.00
Jun 30, 2024 61,000.00
Mar 31, 2024 137.59 Mn
Dec 31, 2023 29,000.00
Sep 30, 2023 109,000.00
Jun 30, 2023 43,000.00
API Access

Alto Neuroscience Net Shares Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-shares-issued-and-repurchased&ticker=ANRO&period=max&api_key=YOUR_API_KEY